Synthetic Data Generation by Artificial Intelligence to Accelerate Research and Precision Medicine in Hematology
JCO Clinical Cancer Informatics · 2023-06 · (7)
DOI: 10.1200/cci.23.00021 ↗Kurz gefasst
Fachartikel in der Zeitschrift JCO Clinical Cancer Informatics, 2023-06. Verfasst von Saverio D'Amico und 28 weiteren Autor:innen. Beteiligte Einrichtung: IRCCS Humanitas Research Hospital, Milan, Italy. Hauptthemen laut MEDLINE: Hematology, Leukemia, Myeloid, Acute. Die Arbeit wurde bisher 77-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
PURPOSE Synthetic data are artificial data generated without including any real patient information by an algorithm trained to learn the characteristics of a real source data set and became widely used to accelerate research in life sciences. We aimed to (1) apply generative artificial intelligence to build synthetic data in different hematologic neoplasms; (2) develop a synthetic validation framework to assess data fidelity and privacy preservability; and (3) test the capability of synthetic data to accelerate clinical/translational research in hematology. METHODS A conditional generative adversarial network architecture was implemented to generate synthetic data. Use cases were myelodysplastic syndromes (MDS) and AML: 7,133 patients were included. A fully explainable validation framework was created to assess fidelity and privacy preservability of synthetic data. RESULTS We generated MDS/AML synthetic cohorts (including information on clinical features, genomics, treatment, and outcomes) with high fidelity and privacy performances. This technology allowed resolution of lack/incomplete information and data augmentation. We then assessed the potential value of synthetic data on accelerating research in hematology. Starting from 944 patients with MDS available since 2014, we generated a 300% augmented synthetic cohort and anticipated the development of molecular classification and molecular scoring system obtained many years later from 2,043 to 2,957 real patients, respectively. Moreover, starting from 187 MDS treated with luspatercept into a clinical trial, we generated a synthetic cohort that recapitulated all the clinical end points of the study. Finally, we developed a website to enable clinicians generating high-quality synthetic data from an existing biobank of real patients. CONCLUSION Synthetic data mimic real clinical-genomic features and outcomes, and anonymize patient information. The implementation of this technology allows to increase the scientific use and value of real data, thus accelerating precision medicine in hematology and the conduction of clinical trials.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- IRCCS Humanitas Research Hospital, Milan, Italy.
- Department of Physics and Astronomy (DIFA), Bologna, Italy.
- Experimental, Diagnostic and Specialty Medicine-DIMES, Bologna, Italy.
- Department of Biomedical Sciences, Humanitas University, Milan, Italy.
- Department of Computer Science & Center for Health Data Science, University of Copenhagen, Copenhagen, Denmark.
- Hematology, Azienda Ospedaliero-Universitaria Careggi & University of Florence, Florence, Italy.
ORCID-Profile: Saverio D'Amico, Daniele Dall'Olio, Claudia Sala, Lorenzo Dall'Olio, Elisabetta Sauta, Matteo Zampini, Gianluca Asti, Luca Lanino, Antonio Russo, Maria Elena Bicchieri, Elena Riva, Pierandrea Morandini, Armando Santoro, Anders Krogh, Valeria Santini, Shahram Kordasti, Uwe Platzbecker, Gastone Castellani, Matteo Giovanni Della Porta
Zitieren
APA
D'Amico, S., Dall'Olio, D., Sala, C., Dall'Olio, L., Sauta, E., Zampini, M., Asti, G., Lanino, L., Maggioni, G., Campagna, A., Ubezio, M., Russo, A., Bicchieri, M. E., Riva, E., Tentori, C. A., Travaglino, E., Morandini, P., Savevski, V., Santoro, A., …, & Della Porta, M. G. (2023). Synthetic Data Generation by Artificial Intelligence to Accelerate Research and Precision Medicine in Hematology. JCO Clinical Cancer Informatics. https://doi.org/10.1200/cci.23.00021
Vancouver
D'Amico S, Dall'Olio D, Sala C, Dall'Olio L, Sauta E, Zampini M, et al. Synthetic Data Generation by Artificial Intelligence to Accelerate Research and Precision Medicine in Hematology. JCO Clinical Cancer Informatics. 2023. doi:10.1200/cci.23.00021
BibTeX
@article{DAmico2023,
author = {D'Amico, Saverio and Dall'Olio, Daniele and Sala, Claudia and Dall'Olio, Lorenzo and Sauta, Elisabetta and Zampini, Matteo and Asti, Gianluca and Lanino, Luca and Maggioni, Giulia and Campagna, Alessia and Ubezio, Marta and Russo, Antonio and Bicchieri, Maria Elena and Riva, Elena and Tentori, Cristina A and Travaglino, Erica and Morandini, Pierandrea and Savevski, Victor and Santoro, Armando and Prada-Luengo, Iñigo and Krogh, Anders and Santini, Valeria and Kordasti, Shahram and Platzbecker, Uwe and Diez-Campelo, Maria and Fenaux, Pierre and Haferlach, Torsten and Castellani, Gastone and Della Porta, Matteo Giovanni},
title = {Synthetic Data Generation by Artificial Intelligence to Accelerate Research and Precision Medicine in Hematology},
journal = {JCO Clinical Cancer Informatics},
year = {2023},
number = {7},
doi = {10.1200/cci.23.00021}
}
EUVIMED